Rosemary Zuna to Cross-Sectional Studies
This is a "connection" page, showing publications Rosemary Zuna has written about Cross-Sectional Studies.
Connection Strength
0.125
-
Evaluation of TypeSeq, a Novel High-Throughput, Low-Cost, Next-Generation Sequencing-Based Assay for Detection of 51 Human Papillomavirus Genotypes. J Infect Dis. 2019 10 08; 220(10):1609-1619.
Score: 0.033
-
Diagnosis of Cervical Precancers by Endocervical Curettage at Colposcopy of Women With Abnormal Cervical Cytology. Obstet Gynecol. 2017 12; 130(6):1218-1225.
Score: 0.029
-
Proof-of-principle study of a novel cervical screening and triage strategy: Computer-analyzed cytology to decide which HPV-positive women are likely to have =CIN2. Int J Cancer. 2017 Feb 01; 140(3):718-725.
Score: 0.027
-
Tubal ligation frequency in Oklahoma women with cervical cancer. Gynecol Oncol. 2012 Nov; 127(2):278-82.
Score: 0.020
-
Human papillomavirus cofactors by disease progression and human papillomavirus types in the study to understand cervical cancer early endpoints and determinants. Cancer Epidemiol Biomarkers Prev. 2009 Jan; 18(1):113-20.
Score: 0.016